The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 39,231,345 | 2,287,542 | SH | SOLE | 2,287,542 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 7,233,200 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 679,500 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | 799,273 | 50,651 | SH | SOLE | 50,651 | 0 | 0 | |||
| AURA BIOSCIENCES INC | COM | 05153U107 | 3,884,575 | 472,576 | SH | SOLE | 472,576 | 0 | 0 | |||
| BIONTECH SE | SPONSORED ADS | 09075V102 | 398,825 | 3,500 | SH | SOLE | 3,500 | 0 | 0 | |||
| CELLECTIS S A | SPON ADS | 15117K103 | 5,546,702 | 3,081,501 | SH | SOLE | 3,081,501 | 0 | 0 | |||
| CORVUS PHARMACEUTICALS INC | PUT | 221015950 | 535,000 | 100,000 | SH | SOLE | Put | 100,000 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 24,164,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| INVESCO QQQ TR | PUT | 46090E953 | 56,235,300 | 110,000 | SH | SOLE | Put | 110,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 7,340,800 | 992,000 | SH | SOLE | 992,000 | 0 | 0 | |||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 387,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| SIGHT SCIENCES INC | COM | 82657M105 | 2,290,907 | 629,370 | SH | SOLE | 629,370 | 0 | 0 | |||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 1,164,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 1,670,412 | 965,556 | SH | SOLE | 965,556 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 319,564 | 7,596 | SH | SOLE | 7,596 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL IN | CALL | 90400D908 | 1,241,065 | 29,500 | SH | SOLE | Call | 29,500 | 0 | 0 | ||
| ZAI LAB LTD | ADR | 98887Q104 | 10,476,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||